Clinical trial
A Phase 2 Study of XL999 in Subjects With Relapsed/Refractory Multiple Myeloma
NCT00304590 is registered in ClinicalTrials.gov with Symphony Evolution, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Study of XL999 in Subjects With Relapsed/Refractory Multiple Myeloma
- Lead sponsor
- Symphony Evolution, Inc.
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- February 28, 2006
- Completion date
- May 31, 2007
- Enrollment
- 4 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.